Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Change in Receivables (2020 - 2025)

Historic Change in Receivables for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to -$255059.0.

  • iSpecimen's Change in Receivables fell 40795.67% to -$255059.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$858078.0, marking a year-over-year decrease of 8512.61%. This contributed to the annual value of $903329.0 for FY2024, which is 26002.63% up from last year.
  • Latest data reveals that iSpecimen reported Change in Receivables of -$255059.0 as of Q3 2025, which was down 40795.67% from -$302646.0 recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Change in Receivables ranged from a high of $1.6 million in Q1 2023 and a low of -$1.4 million during Q2 2023
  • Moreover, its 5-year median value for Change in Receivables was -$93040.0 (2024), whereas its average is -$33243.6.
  • Its Change in Receivables has fluctuated over the past 5 years, first surged by 43165.05% in 2021, then plummeted by 70819.33% in 2025.
  • Quarter analysis of 5 years shows iSpecimen's Change in Receivables stood at $410978.0 in 2021, then crashed by 311.73% to -$870148.0 in 2022, then decreased by 5.19% to -$915269.0 in 2023, then soared by 149.34% to $451570.0 in 2024, then tumbled by 156.48% to -$255059.0 in 2025.
  • Its Change in Receivables stands at -$255059.0 for Q3 2025, versus -$302646.0 for Q2 2025 and -$751943.0 for Q1 2025.